• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New developments in hyperphosphatemia management.

作者信息

Slatopolsky Eduardo

机构信息

Department of Internal Medicine, Washington University of St Louis, St Louis, Missouri, USA.

出版信息

J Am Soc Nephrol. 2003 Sep;14(9 Suppl 4):S297-9. doi: 10.1097/01.asn.0000081668.41546.2b.

DOI:10.1097/01.asn.0000081668.41546.2b
PMID:12939384
Abstract
摘要

相似文献

1
New developments in hyperphosphatemia management.
J Am Soc Nephrol. 2003 Sep;14(9 Suppl 4):S297-9. doi: 10.1097/01.asn.0000081668.41546.2b.
2
[Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].[慢性肾衰竭及透析中高磷血症的纠正方法（综述）]
Ter Arkh. 1997;69(12):63-7.
3
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.透析患者高磷血症和甲状旁腺功能亢进相关风险的重新评估：管理变更建议
Am J Kidney Dis. 2000 Jun;35(6):1226-37. doi: 10.1016/s0272-6386(00)70064-3.
4
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.终末期肾病中磷酸盐结合剂与高磷血症的管理
Nephrol Dial Transplant. 2006 Aug;21(8):2065-8. doi: 10.1093/ndt/gfl289. Epub 2006 Jun 9.
5
[Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].[慢性肾脏病中的心血管钙化与动脉粥样硬化加速]
Ital Heart J Suppl. 2005 Jan;6(1):25-8.
6
[Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].["充足血磷"概念作为高磷血症危险因素的重要性]
Nefrologia. 2003;23 Suppl 2:95-9.
7
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Expert Opin Pharmacother. 2008 Mar;9(4):601-10. doi: 10.1517/14656566.9.4.601.
8
[News in the treatment of hyperphosphatemia].[高磷血症的治疗进展]
Lijec Vjesn. 2004 Sep-Oct;126(9-10):271-3.
9
Resolution of secondary hyperparathyroidism after cadaveric renal allograft.尸体肾移植后继发性甲状旁腺功能亢进的缓解
Proc Eur Dial Transplant Assoc. 1975;11:261-7.
10
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Nefrologia. 2005;25 Suppl 2:100-8.

引用本文的文献

1
Eduardo Slatopolsky: A Pioneer in the Field of Mineral and Bone Disorders in Kidney Disease.爱德华多·斯拉托波尔斯基：肾病矿物质和骨疾病领域的先驱。
Cureus. 2024 Sep 3;16(9):e68543. doi: 10.7759/cureus.68543. eCollection 2024 Sep.
2
Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients.质子泵抑制剂联合醋酸钙对血液透析患者血清磷水平的影响
Caspian J Intern Med. 2023 Fall;14(4):737-740. doi: 10.22088/cjim.14.4.737.
3
Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients.
盐酸司维拉姆对血液透析患者血清尿毒症毒素硫酸吲哚酚和硫酸对甲酚的影响。
J Clin Med Res. 2017 Sep;9(9):765-770. doi: 10.14740/jocmr1803e. Epub 2017 Jul 27.
4
Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis.α-klotho的发现揭示了钙和磷稳态的新见解。
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(3):125-41. doi: 10.2183/pjab.85.125.
5
Hyperphosphatemia in children receiving peritoneal dialysis--an educational program.
Pediatr Nephrol. 2005 Jul;20(7):967-71. doi: 10.1007/s00467-005-1884-y. Epub 2005 May 5.